How Does Codiak BioSciences Inc (CDAK) Stock Rank on Wall Street Friday?

Friday, March 31, 2023 12:14 PM | InvestorsObserver Analysts

Mentioned in this article

How Does Codiak BioSciences Inc (CDAK) Stock Rank on Wall Street Friday?

InvestorsObserver is giving Codiak BioSciences Inc (CDAK) an Analyst Rating Rank of 6, meaning CDAK is ranked higher by analysts than 6% of stocks. The average price target for CDAK is $1.4 and analyst’s rate the stock as a Hold.

Wall Street analysts are rating CDAK a Hold today. Find out what this means to you and get the rest of the rankings on CDAK!

See Full CDAK Report

Why are Analyst Ratings Important?

You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers. InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.

What's Happening With Codiak BioSciences Inc Stock Today?

Codiak BioSciences Inc (CDAK) stock is lower by -8.95% while the S&P 500 is up 0.89% as of 12:10 PM on Friday, Mar 31. CDAK has fallen -$0.02 from the previous closing price of $0.19 on volume of 4,053,986 shares. Over the past year the S&P 500 is lower by -9.79% while CDAK has fallen -97.29%. CDAK lost -$0.68 per share the over the last 12 months. Click Here to get the full Stock Report for Codiak BioSciences Inc stock.